Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psychopharmacology of Psilocybin in Cancer Patients

NCT00465595 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00465595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00465595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psychopharmacology of Psilocybin in Cancer Patients
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2007
Completion date
December 31, 2016
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, cancer, depressive symptoms